🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase III, double-masked, multicenter, randomized, sham inj...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00473382
Treatments Being Tested
This study is designed to compare the post injection inflammation and pain ...
Status
Completed
Location
Sierra Eye Associates
Start Date
2015-01
Trial ID
NCT02363621
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability and ef...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-10-01
Trial ID
NCT02511067
Treatments Being Tested
Ranibizumab is a humanised recombinant monoclonal antibody fragment targete...
Status
Completed
Location
Novartis - 64 sites in 11 countries
Start Date
2006-04
Trial ID
NCT00331864
Treatments Being Tested
This study is a Phase I/II, multicenter, randomized, study of the efficacy ...
Status
Completed
Location
Retina Consultants of Houston
Start Date
2012-03
Trial ID
NCT01552408
Treatments Being Tested
This study is a Phase III, double-masked, multicenter, randomized, sham inj...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00473330
Treatments Being Tested
The primary objectives of this study were to evaluate the safety and effica...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-05-24
Trial ID
NCT03927690
Background: * Diabetic macular edema is a common eye complication of diabe...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-05
Trial ID
NCT01610557
Treatments Being Tested
The purpose of this research study is to determine if a "Treat and Extend" ...
Status
Completed
Location
Retina-Vitreous Associates Medical Group
Start Date
2013-11
Trial ID
NCT01934556
Treatments Being Tested
The study will test if the efficacy and safety of an alternative dosing reg...
Status
Completed
Location
Novartis
Start Date
2005-12
Trial ID
NCT00275821